Chun-Yu Lai1, Hua-Hsin Hsieh1, Hou-Kuang Chen1, Che-Yi Chao2, Chun-Hung Hua1, Chih-Jaan Tai1, DA-Tian Bau3,4, Ming-Hsui Tsai1,3, Liang-Chun Shih5,3. 1. Department of Otorhinolaryngology, China Medical University Hospital, Taichung, Taiwan, R.O.C. 2. Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan, R.O.C. 3. Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C. 4. Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan, R.O.C. 5. Department of Otorhinolaryngology, China Medical University Hospital, Taichung, Taiwan, R.O.C entdrshih7111@gmail.com.
Abstract
BACKGROUND/AIM: Solitary extramedullary plasmacytoma (SEP) is a rare, malignant plasma-cell tumor, which mainly occurs in the head and neck regions. Globally the disease has been rarely happening up to 2019, with only about ten papers focused on SEP cases reported in English. Thus, a literature collectively reviewing the characteristics of the patients would be valuable. PATIENTS AND METHODS: We enrolled 10 SEP patients, and recorded their primary sites and the treatment modality, and analyzed their survival rates and outcomes. We also reviewed previous studies and compared their findings with ours. RESULTS: No gender or age disparity has been observed, and younger patients had a better local control with RT compared to surgery among our patients. CONCLUSION: Further investigations with more patients and long-time follow-up may provide more information for treatment determination and the recurrence and progression from SEP to MM. Copyright
BACKGROUND/AIM: Solitary extramedullary plasmacytoma (SEP) is a rare, malignant plasma-cell tumor, which mainly occurs in the head and neck regions. Globally the disease has been rarely happening up to 2019, with only about ten papers focused on SEP cases reported in English. Thus, a literature collectively reviewing the characteristics of the patients would be valuable. PATIENTS AND METHODS: We enrolled 10 SEP patients, and recorded their primary sites and the treatment modality, and analyzed their survival rates and outcomes. We also reviewed previous studies and compared their findings with ours. RESULTS: No gender or age disparity has been observed, and younger patients had a better local control with RT compared to surgery among our patients. CONCLUSION: Further investigations with more patients and long-time follow-up may provide more information for treatment determination and the recurrence and progression from SEP to MM. Copyright
Authors: P Galieni; M Cavo; A Pulsoni; G Avvisati; C Bigazzi; S Neri; U Caliceti; M Benni; S Ronconi; F Lauria Journal: Haematologica Date: 2000-01 Impact factor: 9.941
Authors: Graça M Dores; Ola Landgren; Katherine A McGlynn; Rochelle E Curtis; Martha S Linet; Susan S Devesa Journal: Br J Haematol Date: 2008-11-11 Impact factor: 6.998